Similar articles for PMID: 22173154

Year	Number of Results
1997	2
1999	2
2001	1
2002	1
2003	4
2004	4
2005	5
2006	3
2007	15
2008	13
2009	21
2010	25
2011	25
2012	27
2013	30
2014	25
2015	20
2016	17
2017	15
2018	6
2019	10
2020	7
2021	9
2022	3
2023	1
2024	0

1

High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.

Ma SW, Huang X, Li YY, Tang LB, Sun XF, Jiang XT, Zhang YX, Sun J, Liu ZH, Abbott WG, Dong YH, Naoumov NV, Hou JL. Ma SW, et al. J Hepatol. 2012 Apr;56(4):775-81. doi: 10.1016/j.jhep.2011.10.020. Epub 2011 Dec 13. J Hepatol. 2012. PMID: 22173154 Clinical Trial.

2

Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.

Evans A, Riva A, Cooksley H, Phillips S, Puranik S, Nathwani A, Brett S, Chokshi S, Naoumov NV. Evans A, et al. Hepatology. 2008 Sep;48(3):759-69. doi: 10.1002/hep.22419. Hepatology. 2008. PMID: 18697210

3

A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.

Zheng MH, Shi KQ, Dai ZJ, Ye C, Chen YP. Zheng MH, et al. Clin Ther. 2010 Apr;32(4):649-58. doi: 10.1016/j.clinthera.2010.04.001. Clin Ther. 2010. PMID: 20435234 Clinical Trial.

4

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han SH, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, Chen Y, Brown NA, Albanis E, Galil K, Naoumov NV; GLOBE Study Group. Liaw YF, et al. Gastroenterology. 2009 Feb;136(2):486-95. doi: 10.1053/j.gastro.2008.10.026. Epub 2008 Nov 1. Gastroenterology. 2009. PMID: 19027013 Clinical Trial.

5

Telbivudine versus lamivudine in patients with chronic hepatitis B.

Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, Chen Y, Heathcote EJ, Rasenack J, Bzowej N, Naoumov NV, Di Bisceglie AM, Zeuzem S, Moon YM, Goodman Z, Chao G, Constance BF, Brown NA; Globe Study Group. Lai CL, et al. N Engl J Med. 2007 Dec 20;357(25):2576-88. doi: 10.1056/NEJMoa066422. N Engl J Med. 2007. PMID: 18094378 Free article. Clinical Trial.

6

Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.

Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L. Chen Y, et al. Antiviral Res. 2011 Jul;91(1):23-31. doi: 10.1016/j.antiviral.2011.04.008. Epub 2011 Apr 23. Antiviral Res. 2011. PMID: 21549152

7

A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.

Tsai MC, Lee CM, Chiu KW, Hung CH, Tung WC, Chen CH, Tseng PL, Chang KC, Wang JH, Lu SN, Yen YH, Hu TH. Tsai MC, et al. J Antimicrob Chemother. 2012 Mar;67(3):696-9. doi: 10.1093/jac/dkr495. Epub 2011 Dec 15. J Antimicrob Chemother. 2012. PMID: 22174039

8

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.

Gane EJ, Wang Y, Liaw YF, Hou J, Thongsawat S, Wan M, Moon YM, Jia J, Chao YC, Niu J, Leung N, Samuel D, Hsu CW, Bao W, Lopez P, Avila C. Gane EJ, et al. Liver Int. 2011 May;31(5):676-84. doi: 10.1111/j.1478-3231.2011.02490.x. Epub 2011 Mar 16. Liver Int. 2011. PMID: 21457439 Clinical Trial.

9

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J. Hou J, et al. Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075. Hepatology. 2008. PMID: 18080339 Clinical Trial.

10

[Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].

Xie DY, Lin BL, Chen FJ, Deng H, Chong YT, Zhang XH, Gao ZL. Xie DY, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Sep;18(9):646-50. doi: 10.3760/cma.j.issn.1007-3418.2010.09.002. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20943073 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

255 results

Results by year